about
Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsyEnhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy.BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes.Some properties of human neuronal alpha 7 nicotinic acetylcholine receptors fused to the green fluorescent protein.The single-channel properties of human acetylcholine alpha 7 receptors are altered by fusing alpha 7 to the green fluorescent protein.Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranesExpression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy.Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.Microtransplantation of membranes from cultured cells to Xenopus oocytes: a method to study neurotransmitter receptors embedded in native lipidsSelective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.Physiological characterization of human muscle acetylcholine receptors from ALS patients.Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain.Co-expression of the neuronal alpha7 and L247T alpha7 mutant subunits yields hybrid nicotinic receptors with properties of both wild-type alpha7 and alpha7 mutant homomeric receptorsNeuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domainsAcetylcholine receptors from human muscle as pharmacological targets for ALS therapy.Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information.Modulation of GABAA receptors in the treatment of epilepsy.Neuroinflammatory targets and treatments for epilepsy validated in experimental models.Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives.Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions.Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats.The desensitization of the embryonic mouse muscle acetylcholine receptor depends on the cellular environment.Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy.Riluzole blocks human muscle acetylcholine receptors.Inhibition of nicotinic acetylcholine receptors by bicuculline.Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.Properties of neuronal alpha7 mutant nicotinic acetylcholine receptors gated by bicuculline.The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis.Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy.Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex.Phorbol ester modulation of both delta-mutant and subunit-omitted nicotinic receptors expressed in Xenopus oocytes.Nicotinic acetylcholine receptors assembled from the alpha7 and beta3 subunits.Protein kinase C modulates exogenous acetylcholine current in Xenopus oocytes.Age-dependent appearance of synaptic currents in rat neocortical neurons in culture.A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy.Neurobiological Correlates of Alpha-Tocopherol Antiepileptogenic Effects and MicroRNA Expression Modulation in a Rat Model of Kainate-Induced Seizures.
P50
Q30476285-B8FDF43F-612E-4E61-A505-A23B88072BF8Q30493725-795458D5-BB15-4DD8-8B65-8DD922F276E1Q33818453-7C16DFF0-0499-4EB6-AB11-3FD9A22FDACDQ34021316-68A28C8C-1DA0-4728-9805-1747842762DFQ34021334-BCD8F6AB-C240-4216-B32A-B4ED22848EC6Q34192342-C4D0A69F-AFE1-4751-879B-77DCB64C8E38Q34381258-EEAB90D4-D9E3-48D3-AE3C-38CF89B03DEBQ34694335-C3A74F86-41D0-4187-8A2E-A8E8E254CADDQ34809010-62B235A7-F6C9-475E-8FB8-B5F500DB4D31Q35028391-56C9C767-3DA4-40AD-B1B2-F27BB3D36D87Q35647484-144578A9-F5B4-470C-A615-D2BDC5DFEF8AQ35971812-7CE29120-9BAB-4850-9B5A-1E71F2E9612CQ35998842-98B1F0A3-A204-4E87-8F7E-7F14809D15F0Q36578906-619C3709-4D6C-492C-BB44-ED97178EC4A9Q36676165-106C4B16-5AE0-4FCA-86BF-28ABB4F5236FQ36710671-272863AF-93A9-4200-9FBF-487A80B1A25FQ37317700-EF5A2914-52F5-40EF-9CD9-2735B95E2AA8Q37476125-AB206A0A-9EBB-4950-9897-FBE0D833C6A6Q38643908-81B73CE1-8F0C-4B09-9C4A-77C3A4472118Q38662997-05AA500B-C653-4F63-B64B-079572D9FC56Q38809433-65BF806E-BD12-4737-AC98-EB6AA5B92342Q39593379-9A494B8C-5312-4CFD-B080-3DBAA9B56BE7Q40673378-F92FE56F-9B71-43E8-8C23-A8D796934C90Q40836460-DF2AD0E7-463E-4503-8F0C-1412D646438CQ41307546-49459FAC-D3BC-49E0-AFCA-283233A5AD5CQ42457999-FD2D5F53-5DFF-4B12-97A0-28938DFA6809Q42640644-C497C2C7-12DE-4444-9D1C-B424F42869A1Q43782822-ACC65010-6503-4ABC-BE71-D0D7ED390734Q43908063-02D95DE6-6B2D-438C-9CCF-12CC14DE727CQ44394165-2377D64D-014F-4A51-B90A-AB600AB48953Q48158790-72DDE9C0-2E75-4815-9F36-5253DC70710CQ48574002-AEBCE164-7374-48BE-9AED-87CE546882F3Q48617885-C0FFB85B-D127-4EAD-8022-2741F99D2111Q48671988-19DABDC7-BEB5-4D83-8B86-44DFC939A0E2Q48831638-FBFBF83A-950E-414B-8A63-F931ECBB32B7Q48915237-C7DFAFED-25C4-430F-8860-2E3ED5E17CE2Q49049059-075722FD-5B9F-4929-B52F-B29D1186F2F0Q51626795-3521E756-62C5-4193-956A-785EC0CF7935Q52604399-0C4EAA82-AA0B-40F4-813A-388F7B4E7995Q52691067-8375D9C2-9786-4BD6-A3B8-7A99E6686E29
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Eleonora Palma
@ast
Eleonora Palma
@en
Eleonora Palma
@es
Eleonora Palma
@nl
Eleonora Palma
@sl
type
label
Eleonora Palma
@ast
Eleonora Palma
@en
Eleonora Palma
@es
Eleonora Palma
@nl
Eleonora Palma
@sl
prefLabel
Eleonora Palma
@ast
Eleonora Palma
@en
Eleonora Palma
@es
Eleonora Palma
@nl
Eleonora Palma
@sl
P1053
A-2775-2010
P106
P1153
7101815915
P21
P214
8700155044753872520009
P2798
P31
P3829
P496
0000-0001-6026-927X
P734
P735
P7859
viaf-8700155044753872520009